Order Article Reprints

Franko A, Irmler M, Prehn C, Heinzmann SS, Schmitt-Kopplin P, Adamski J, Beckers J, von Kleist-Retzow J-C, Wiesner R, Häring H-U, et al. Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice. Biomedicines. 2022; 10(3):616. https://doi.org/10.3390/biomedicines10030616

Franko, Andras, Martin Irmler, Cornelia Prehn, Silke S. Heinzmann, Philippe Schmitt-Kopplin, Jerzy Adamski, Johannes Beckers, Jürgen-Christoph von Kleist-Retzow, Rudolf Wiesner, Hans-Ulrich Häring, and et al. 2022. "Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice" Biomedicines 10, no. 3: 616. https://doi.org/10.3390/biomedicines10030616

Franko, A., Irmler, M., Prehn, C., Heinzmann, S. S., Schmitt-Kopplin, P., Adamski, J., Beckers, J., von Kleist-Retzow, J.-C., Wiesner, R., Häring, H.-U., Heni, M., Birkenfeld, A. L., & de Angelis, M. H. (2022). Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice. Biomedicines, 10(3), 616. https://doi.org/10.3390/biomedicines10030616